Changing the Game
Founded in 2018, Hopewell Therapeutics Inc. is a startup pharmaceutical and biotechnology company based in Woburn, Massachusetts.
Our Boston-based biotechnology raises the tides of life through a new class of mRNA therapies, using organ and cell-specific biodegradable lipid nanoparticles (LNPs) to address unmet medical needs, including immuno-oncology and regenerative medicine.
We also develop novel synthetic biodegradable LNPs for the delivery of nucleic acids in gene therapy and editing. We have identified several different LNPs that can deliver cargos in organ and cell specific manners using our licensed technology from Tufts University.